| Kepivance® (palifermin) - Protection Against Severe Oral Mucositis Kepivance ® is indicated to decrease the incidence and duration of severe oral mucositis in patients with hematologic malignancies receiving myelotoxic therapy ... Read More |
| Palifermin - Wikipedia, the free encyclopedia Palifermin (trade name Kepivance, marketed by Biovitrum) is a human recombinant keratinocyte growth factor (KGF) produced in Escherichia coli. KGF stimulates the ... Read More |
| palifermin medical facts from Drugs.com Physician reviewed palifermin patient information - includes palifermin description, dosage and directions. Read More |
| Palifermin: MedlinePlus Drug Information - National Library of ... Your doctor has ordered palifermin to help treat your illness. The drug is given by injection into a vein. You will probably be given three doses of ... Read More |
| Palifermin - National Cancer Institute - Comprehensive Cancer ... This page contains brief information about palifermin and a collection of links to more information about the use of this drug, research results, and ongoing clinical ... Read More |
| Palifermin Facts and Comparisons at Drugs.com All about Palifermin. View complete and up to date Palifermin information - part of the Drugs.com trusted medication database. Read More |
| Kepivance (Palifermin) Drug Information: Description, User Reviews ... Learn about the prescription medication Kepivance (Palifermin), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| Palifermin - Side Effects, Dosage, Interactions - Drugs ... Palifermin - Palifermin is a human keratinocyte growth factor (KGF) produced by recombinant DNA technology. - Palifermin is given as an I .V. (in the vein) infusion ... Read More |
| palifermin - definition of palifermin in the Medical dictionary ... palifermin Kepivance Pharmacologic class: Keratinocyte growth factor (KGF) (rDNA origin) Therapeutic class: Biologic and immunologic agent Pregnancy risk category C ... Read More |
| Single-dose palifermin prevents severe oral mucositis during ... 1. Ann Intern Med. 2010 Sep 21;153(6):358-67. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a ... Read More |
